Journal
Clinical Infectious Diseases
Publication Date
8-16-2018
Volume
67
Issue
5
First Page
649
Last Page
656
Document Type
Open Access Publication
DOI
10.1093/cid/ciy171
Rights and Permissions
Dale N Gerding, Ciaran P Kelly, Galia Rahav, Christine Lee, Erik R Dubberke, Princy N Kumar, Bruce Yacyshyn, Dina Kao, Karen Eves, Misoo C Ellison, Mary E Hanson, Dalya Guris, Mary Beth Dorr, Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence, Clinical Infectious Diseases, Volume 67, Issue 5, 1 September 2018, Pages 649–656, https://doi.org/10.1093/cid/ciy171. © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. DOI: 10.1093/cid/ciy171. https://academic.oup.com/cid/article/67/5/649/4925796.
Recommended Citation
Gerding, Dale N.; Kelly, Ciaran P.; Rahav, Galia; Lee, Christine; Dubberke, Erik R.; Kumar, Princy N.; Yacyshyn, Bruce; Kao, Dina; Eves, Karen; Ellison, Misoo C.; Hanson, Mary E.; Guris, Dalya; and Dorr, Mary Beth, "Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence." Clinical Infectious Diseases. 67, 5. 649 - 656. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/8938
